[Other] Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial |
|
This post will be closed automatically in 2026-10-02 01:18
Reward10points
|
post
reply
points
680
20
Classifying Concrete Permeability Using Rapid Chloride Permeability and Surface Resistivity Tests: Benefits, Limitations, and Predictive Models〞A State-of-the-Art Review
90
false allegations of sexual abuse and their apparent credibility
70
A randomized, placebo-controlled, double-blinded, parallel-group, 5-week study of buprenorphine transdermal system in adults with osteoarthritis
70
La morte improvvisa giovanile e in et角 adulta: cause e concause. L＊esperienza della rete multidisciplinare in Emilia-Romagna
70
Safety and effectiveness of antifungal prophylaxis in preventing fungal infection after liver transplantation: a meta-analysis of randomized clinical trials
